Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronedarone vs amiodarone for maintenance of sinus rhythm in atrial fibrillation
2006-005804-15Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dronedarone in Atrial fibrillation (AFib) (2 arms), sponsored by Sanofi. Primary endpoint: Treatment failure. Started Feb 2007; status: completed.
02
Drugs
dronedarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2006-005804-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005804-15.